Health Policy

Portugal's INFARMED has blocked public funding for Datroway in breast cancer, citing insufficient added value.

🚀 How is the India-SACU trade agreement unlocking new pharma growth? This landmark deal is expanding market access, cutting tariffs, and accelerating exports for Indian pharmaceutical companies across Southern Africa. Discover the strategic opportunities it creates for the sector. #SyenzaNews #pharmaceuticals #globalhealth #innovation #MarketAccess

Can local procurement policies turn the tide for South Africa’s pharmaceutical jobs? A strategic shift toward prioritizing local pharma manufacturing could safeguard thousands of positions while strengthening supply chain resilience and economic growth. This approach balances cost considerations with long-term industrial development in the sector. Explore the full analysis. #SyenzaNews #pharmaceuticals #MarketAccess #healthcarepolicy

📈 How is the GLP-1 surge reshaping pharmaceutical forecasts? Novo Nordisk has raised its full-year profit guidance, propelled by explosive demand for its GLP-1 therapies in diabetes and obesity care. Discover the market forces behind this momentum. #SyenzaNews #pharmaceuticals #biotech #innovation #MarketAccess

⚠️ What breaches were uncovered in a Portuguese surgeon’s disciplinary review? A recent investigation has exposed serious lapses in clinical standards and regulatory compliance, raising fresh questions about accountability in surgical practice. Read the full analysis to see what this means for patient safety and oversight. #SyenzaNews #regulatoryaffairs #HealthcareInnovation #governance #innovation

How is South Africa advancing local production of cutting-edge HIV treatments? The country has shortlisted manufacturers for Lenacapavir, paving the way for greater domestic capacity, improved access, and stronger pharmaceutical supply chains across the region. Explore how this step supports broader drug development goals. #SyenzaNews #pharmaceuticals #drugdevelopment #innovation #MarketAccess

Is integrated care in Canada losing momentum? Walter Wodchis’ blueprint outlines a practical path to coordinated, patient-centered services, yet progress has stalled amid structural and policy barriers. This analysis explores the key challenges and what’s needed to move forward. Read the full breakdown to see how Canada can get integrated care back on track. #SyenzaNews #HealthcareInnovation #healthcare #innovation #healthcarepolicy

Is the Dutch health insurance fund heading back into the red? Projections show the Zorgverzekeringsfonds returning to an operating deficit in 2026, raising fresh questions about long-term sustainability and the balance between premiums, benefits, and public spending. Read the full analysis to see what this means for healthcare financing. #SyenzaNews #healthcare #HealthEconomics #MarketAccess #healthcarepolicy

How is Portugal expanding access to advanced prostate cancer therapies? The country has approved reimbursement for the niraparib-abiraterone combination, strengthening patient options in oncology and highlighting progress in pharmaceutical market access. Discover what this means for treatment innovation and healthcare policy. #SyenzaNews #oncology #MarketAccess

🚀 What sparked China's pharmaceutical innovation surge after 2016? Key regulatory reforms streamlined approvals and accelerated R&D, rapidly elevating the country’s role in global drug development. Explore the data and trends behind this transformation. #SyenzaNews #pharmaceuticals #drugdevelopment #innovation #MarketAccess

What happens when Medicare Part D subsidies end? Beneficiaries could see modest premium increases next year as federal support phases out, potentially shifting more costs to seniors and affecting prescription drug affordability across the U.S. Explore the latest analysis on these changes and their market implications. #SyenzaNews #healthcare #HealthEconomics #healthcarepolicy #costeffectiveness

🌍 Are Portugal’s children facing unequal health opportunities based on where they live? A new national survey reveals significant regional gaps in child health outcomes, highlighting disparities in access, prevention, and care that demand targeted policy action. Read the full analysis to see what these findings mean for equitable health strategies. #SyenzaNews #globalhealth #HealthEconomics #healthcarepolicy #economicanalysis